Support for Vaccine Development Deadline: 30 October 2015 5:00 p.m. CET Anticipated Decision Date 30 November 2015 The High Impact project on Advanced Immunization Technologies (ADITEC), funded through the 7th Framework Programme of the European Union, aims to accelerate the […]
Adjuvanted trivalent influenza vaccine study in infants: A randomised controlled trial to determine the kinetics of the functional genomic response In the 2012 influenza season, ADITEC partners (Geneva, Oxford, Emory and Novartis) conducted a randomised controlled trial to assess the kinetics […]
Happy New Year! The ADITEC project team wishes all partners, collaborators and those who are interested in our work, a very Happy New year! In 2015 we will continue developing advanced immunization technologies in order to improve health and wellness. […]
Support for Vaccine Development Deadline: 30 Jan 2015 5:00 p.m. CET Anticipated Decision Date 8 April 2015 The High Impact project on Advanced Immunization Technologies (ADITEC), funded through the 7th Framework Programme of the European Union, aims to accelerate the […]